Welcome! If you have any pricing inquiries, please don't hesitate to reach out to us using the form on the left side. We'll respond to you promptly.
CD Formulation supports antibody-based therapies with expertise in antibody engineering and drug delivery, optimizing the stability, specificity, and effectiveness of delivery systems. Through the use of antibody-drug conjugates (ADCs), liposomes, viral vectors and other proprietary platforms, we can precisely target therapeutic antibodies to specific sites while minimizing the risk of adverse effects.
Delivery systems for antibodies and their mechanisms of cellular entry (Singh K.; et al., 2019)
We have expertise in recombinant antibody expression using various host systems such as mammalian cells, yeast, or bacteria. Our team optimizes expression conditions to maximize yield and quality. Additionally, we employ advanced purification techniques, including affinity chromatography, size-exclusion chromatography, and ion exchange chromatography, to obtain highly purified antibodies.
We specialize in the development of antibody formulations, catering to various administration routes such as injections, powder injections, and inhalation preparations. By leveraging cutting-edge formulation technologies, we help clients successfully navigate antibody development into different administration formats, allowing for long-acting depots, precise pulmonary targeting, and versatile dosage forms.
CD Formulation has extensive experience engineering a variety of nanoparticles. Our formulation scientists can customize nanoparticles from polymers, lipids or inorganic nanomaterials with properties tailored to specific antibodies and applications. We also incorporate surface modifications to improve targeting capabilities and minimize immunogenicity.
Our capabilities extend to the development of antibody complexes, enabling the formation of versatile therapeutic entities. We utilize our antibody engineering and multivalent display technologies to conjugate antibodies to other biomolecules such as peptides, proteins, and drug moieties.
Our team of formulation scientists can functionalize nanoparticles, liposomes, viral vectors, and other biomimetic systems with antibodies to enable homing to specific antigens overexpressed in diseased cells and tissues. We optimize the density, orientation, and conjugation methods of the antibody modifications to preserve targeting ability.
Leveraging our expertise in protein engineering and monoclonal antibody development, CD Formulation provides comprehensive humanization services. We have the capabilities to analyze antibody sequences, identify variable and constant regions derived from non-human species, and graft them onto human frameworks using structure-guided computational design and molecular modeling.
Antibody delivery system development services at CD Formulation are designed to provide tailored solutions for optimizing the efficacy, specificity, and safety of antibody-based therapies. Contact us now to explore how our services can advance your therapeutic research and development!
References